相关产品推荐更多 >

Rabbit anti-ANGPTL3 Recombinant Monoclonal Antibody(425-5)【兔抗ANGPTL3重组单克隆抗体(425-5)】- abs190788
询价
PE Mouse anti-Human CD54 Antibody(15.2)【PE鼠抗人CD54抗体(15.2)】- abs1840976
¥900
FITC Mouse Anti-Human CD2 Antibody (S-633-25)【异硫氰酸荧光素(FITC)标记的小鼠抗人CD2抗体(S - 633 - 25)】
¥520
Rabbit anti-Cyclin D1 Monoclonal Antibody【兔抗细胞周期蛋白D1单克隆抗体】- abs155983
¥1800
Abd serotec二抗 抗猪 MOUSE ANTI PIG IgM
询价
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
从原料到标记,打造属于中国自己的流式抗体品牌abinScience 体内级抗体,年度锁价,低至 1200五大应用案例:Mustang Q 膜层析应用全解析1 个小工具,一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 抗体名:
AF700 Mouse anti-Human CD4 mAb(S-574-16)
- 抗体英文名:
AF700 Mouse anti-Human CD4 Antibody(S-574-16)
- 靶点:
见优宁维官网
- 浓度:
0.2mg/mL
- 应用范围:
FCM(Extra): 1μg per million cells in 100μl volume
- 宿主:
Mouse
- 适应物种:
见优宁维官网
- 保质期:
见优宁维官网
- 抗原来源:
见优宁维官网
- 级别:
优级
- 库存:
999
- 供应商:
Absin
- 标记物:
Alexa Fluor 700
- 克隆性:
S-574-16
- 保存条件:
Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
- 免疫原:
Recombinant Protein
- 规格:
100uL/25uL/10uL/1mL
| 规格: | 100uL | 产品价格: | ¥3700.0 |
|---|---|---|---|
| 规格: | 25uL | 产品价格: | ¥1056.0 |
| 规格: | 10uL | 产品价格: | ¥458.0 |
| 规格: | 1mL | 产品价格: | 询价 |
别名:AF700鼠抗人CD4抗体(S-574-16)
免疫原:Recombinant Protein
应用:FCM(Extra): 1μg per million cells in 100μl volume
保持条件:Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
使用方法:FlowCytometry
标记:Alexa Fluor 700
宿主:Mouse
反应种属:见优宁维官网
克隆性:S-574-16
产品描述:见优宁维官网
爱必信品牌介绍:

更多详情请了解优宁维网站》》
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验(1 ). In our laboratory, we have developed methods to immortalize specific antibody-producing cells by fusing secreting EBV-activated lymphocytes to mouse-human heteromyeloma cell lines with electrofusion, followed by cloning (2 ). This methodology has allowed
祝贺〖雅裕睿安〗成为Signalway Antibody(SAB)独家
Secondary antibody unconjugated; 货号3022,产品描述:Goat anti-Human IgG Secondary antibody HRP conjugated; 货号3031,产品描述:Goat anti-Mouse IgG Secondary antibody unconjugated; 货号3032,产品描述:Goat anti-Mouse IgG Secondary
【翻译】Development trends for monoclonal antibody cancer therapeutics
in the mid- to late 1980s (Refs 12–14). In addition, human mAbs derived from phage display and transgenic mice became available in the 1990s (Refs 15, 16). It should be noted that human mAbs were also made from human hybridomas, but this production method
技术资料暂无技术资料 索取技术资料






